Last checked at 2 Jul 2021 13:34
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | AON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 01 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
560,577 | 0.25% | 1,697,165 | 0.75% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
274,019 | 0.12% | 0 | 0.00% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 24,200 | 0.01% | 24,200 | 0.01% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
858,796 | 0.38% | 1,721,365 | 0.76% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 3 | 238.4100 USD |
Purchase | 9 | 239.1950 USD |
Purchase | 24 | 239.2900 USD |
Purchase | 25 | 238.9192 USD |
Purchase | 26 | 238.7850 USD |
Purchase | 38 | 239.0158 USD |
Purchase | 39 | 238.9251 USD |
Purchase | 47 | 238.9953 USD |
Purchase | 50 | 238.7100 USD |
Purchase | 79 | 238.7410 USD |
Purchase | 100 | 238.4550 USD |
Purchase | 100 | 238.4050 USD |
Purchase | 100 | 239.2400 USD |
Purchase | 100 | 239.0200 USD |
Purchase | 100 | 238.9000 USD |
Purchase | 113 | 238.7346 USD |
Purchase | 125 | 238.4314 USD |
Purchase | 137 | 238.7667 USD |
Purchase | 214 | 238.6815 USD |
Purchase | 361 | 240.1495 USD |
Purchase | 400 | 238.7400 USD |
Purchase | 500 | 238.7980 USD |
Purchase | 630 | 238.4825 USD |
Purchase | 700 | 238.4000 USD |
Purchase | 796 | 238.6800 USD |
Purchase | 900 | 238.8291 USD |
Purchase | 1,145 | 238.7350 USD |
Purchase | 1,258 | 238.9120 USD |
Purchase | 1,875 | 238.6650 USD |
Purchase | 2,505 | 238.7874 USD |
Purchase | 2,539 | 238.7870 USD |
Purchase | 2,548 | 239.0738 USD |
Purchase | 2,883 | 239.1472 USD |
Purchase | 3,020 | 238.7711 USD |
Purchase | 4,481 | 238.8522 USD |
Purchase | 6,684 | 238.7717 USD |
Purchase | 15,602 | 238.8146 USD |
Purchase | 36,200 | 238.7759 USD |
Sale | 2 | 239.0700 USD |
Sale | 3 | 239.0100 USD |
Sale | 9 | 239.1950 USD |
Sale | 17 | 240.2200 USD |
Sale | 36 | 238.9983 USD |
Sale | 43 | 238.8102 USD |
Sale | 48 | 238.6870 USD |
Sale | 50 | 238.7100 USD |
Sale | 50 | 238.4500 USD |
Sale | 418 | 238.7400 USD |
Sale | 453 | 238.9166 USD |
Sale | 544 | 238.8486 USD |
Sale | 800 | 238.4006 USD |
Sale | 841 | 238.8852 USD |
Sale | 918 | 238.8880 USD |
Sale | 919 | 238.9595 USD |
Sale | 1,209 | 238.9655 USD |
Sale | 1,557 | 238.6800 USD |
Sale | 2,412 | 238.7063 USD |
Sale | 4,409 | 239.1793 USD |
Sale | 12,565 | 238.8056 USD |
Sale | 59,685 | 238.7828 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 2 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -1,200 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 1,200 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 23,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -23,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210702005202/en/
Copyright Business Wire 2021